Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 30 11:21AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.67 Insider Own17.68% Shs Outstand15.98M Perf Week-2.97%
Market Cap26.61M Forward P/E- EPS next Y-1.00 Insider Trans38.77% Shs Float15.05M Perf Month-32.93%
Income-12.61M PEG- EPS next Q-0.55 Inst Own12.04% Short Float4.44% Perf Quarter-57.93%
Sales0.00M P/S- EPS this Y-6.92% Inst Trans- Short Ratio5.47 Perf Half Y-70.77%
Book/sh-0.51 P/B- EPS next Y28.06% ROA-54.35% Short Interest0.67M Perf Year-74.91%
Cash/sh0.34 P/C4.26 EPS next 5Y- ROE-202.12% 52W Range1.27 - 7.59 Perf YTD-75.12%
Dividend Est.- P/FCF- EPS past 5Y32.71% ROI- 52W High-80.82% Beta1.27
Dividend TTM- Quick Ratio2.99 Sales past 5Y0.00% Gross Margin- 52W Low14.62% ATR (14)0.19
Dividend Ex-Date- Current Ratio2.99 EPS Y/Y TTM7.72% Oper. Margin0.00% RSI (14)33.09 Volatility11.79% 10.45%
Employees12 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price18.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q7.71% Payout- Rel Volume0.56 Prev Close1.54
Sales Surprise- EPS Surprise-255.00% Sales Q/Q- EarningsMar 19 BMO Avg Volume121.97K Price1.46
SMA20-20.94% SMA50-34.74% SMA200-65.28% Trades Volume22,043 Change-5.49%
Date Action Analyst Rating Change Price Target Change
Feb-14-22Initiated H.C. Wainwright Buy $25
Today 08:00AM
May-28-24 08:00AM
May-24-24 08:00AM
May-21-24 07:39AM
04:33PM Loading…
May-17-24 04:33PM
May-15-24 08:00AM
Apr-24-24 08:00AM
Apr-10-24 08:00AM
Apr-09-24 08:00AM
Mar-19-24 06:52AM
Mar-07-24 08:00AM
Mar-06-24 08:00AM
Feb-27-24 08:00AM
Feb-07-24 08:00AM
08:30AM Loading…
Feb-06-24 08:30AM
Jan-30-24 10:48PM
Jan-04-24 08:45AM
Dec-28-23 08:55AM
Dec-20-23 08:40AM
Dec-06-23 09:31AM
Nov-30-23 07:00AM
Nov-03-23 08:31AM
Nov-01-23 10:49AM
Oct-25-23 09:15AM
Oct-20-23 09:15AM
Oct-18-23 09:00AM
Oct-11-23 09:10AM
Oct-04-23 09:00AM
09:00AM Loading…
Oct-03-23 09:00AM
Sep-08-23 07:00AM
Aug-31-23 11:54AM
Aug-25-23 02:33PM
Aug-18-23 12:21PM
Aug-16-23 08:36AM
Jul-10-23 07:00AM
Jun-27-23 08:05AM
May-25-23 09:00AM
May-19-23 11:38AM
May-15-23 08:00AM
Apr-27-23 05:33AM
Apr-17-23 07:45AM
Apr-10-23 07:29AM
Mar-30-23 08:45AM
Mar-15-23 09:15AM
Mar-14-23 06:27AM
Mar-09-23 04:56AM
Feb-23-23 08:00AM
Feb-11-23 07:13AM
Feb-09-23 11:09PM
Jan-24-23 09:07AM
Jan-23-23 12:06PM
Jan-20-23 12:15PM
Jan-18-23 08:47AM
Jan-10-23 09:00AM
Dec-19-22 06:16AM
Dec-08-22 09:25AM
Dec-02-22 10:00AM
Nov-30-22 08:04AM
Nov-21-22 05:10AM
Nov-15-22 08:00AM
Nov-10-22 09:00AM
Oct-31-22 07:54AM
Oct-21-22 09:00AM
Oct-14-22 07:13AM
Oct-12-22 09:00AM
Sep-28-22 09:15AM
Sep-14-22 09:20AM
Sep-07-22 09:25AM
Aug-17-22 10:13AM
Aug-05-22 02:41PM
Aug-04-22 09:00AM
Jul-21-22 08:23AM
Jul-05-22 09:00AM
Jun-29-22 09:00AM
Jun-24-22 09:00AM
Jun-23-22 07:40AM
May-18-22 09:15AM
May-06-22 03:02PM
Apr-13-22 08:00AM
Apr-12-22 04:30PM
Apr-07-22 08:30AM
Mar-29-22 05:44AM
Feb-28-22 08:00AM
Feb-23-22 08:00AM
Feb-16-22 08:00AM
Feb-11-22 04:12AM
Feb-10-22 11:00AM
Jan-19-22 04:57PM
Jan-11-22 09:00AM
Jan-05-22 05:15AM
Dec-29-21 08:48PM
Dec-16-21 08:00AM
Dec-09-21 09:00AM
Nov-18-21 09:00AM
Nov-12-21 09:00AM
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lustig MarcDirectorMay 14 '24Buy2.21902,9352,000,0012,542,935May 20 04:00 PM